India and South Africa have petitioned the World Trade Organization to suspend intellectual property protections for Covid-19 vaccines. These nations – along with a coalition of scholars, activists, and nonprofit organizations – argue that developing nations are at risk of waiting years to get full access to the vaccines unless these protections are lifted. But their opponents say suspending patent protections will do little to speed up the manufacturing process. Instead, undermining these protections will ensure that the next time the world needs an emergency vaccine, governments and pharmaceuticals will be unable to act as swiftly. It’s a debate emblematic of the uneven vaccine rollout, and strikes at the core of society’s ability to act quickly.
Thomas Cueni -
Director General, International Federation of Pharmaceutical Manufacturers & Associations
Thomas Cueni is Director General of IFPMA, the global association of pharmaceutical research compani... read bio
Against The Motion
Brook Baker -
Professor, Northeastern University
Professor Baker teaches disability discrimination law, negotiations and a new course on human rights... read bio
Watch - Listen - Learn
Intelligent topics, Intelligent debates - Now available wherever you are
A nonpartisan, nonprofit organization, Intelligence Squared U.S. addresses a fundamental problem in America: the extreme polarization of our nation and our politics.
Our mission is to restore critical thinking, facts, reason, and civility to American public discourse.